annual cash & cash equivalents:
$264.55M+$209.65M(+381.89%)Summary
- As of today (September 10, 2025), CRNX annual cash & cash equivalents is $264.55 million, with the most recent change of +$209.65 million (+381.89%) on December 31, 2024.
- During the last 3 years, CRNX annual cash & cash equivalents has risen by +$63.85 million (+31.81%).
- CRNX annual cash & cash equivalents is now at all-time high.
Performance
CRNX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.20B-$77.76M(-6.10%)Summary
- As of today (September 10, 2025), CRNX quarterly cash & cash equivalents is $1.20 billion, with the most recent change of -$77.76 million (-6.10%) on June 30, 2025.
- Over the past year, CRNX quarterly cash & cash equivalents has increased by +$333.91 million (+38.69%).
- CRNX quarterly cash & cash equivalents is now -11.64% below its all-time high of $1.35 billion, reached on December 31, 2024.
Performance
CRNX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CRNX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +381.9% | +38.7% |
| 3 y3 years | +31.8% | +193.0% |
| 5 y5 years | +556.0% | +483.4% |
CRNX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +709.7% | -11.6% | +352.4% |
| 5 y | 5-year | at high | +709.7% | -11.6% | +694.4% |
| alltime | all time | at high | +2077.0% | -11.6% | +8333.3% |
CRNX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.20B(-6.1%) |
| Mar 2025 | - | $1.27B(-5.9%) |
| Dec 2024 | $264.55M(+381.9%) | $1.35B(+57.0%) |
| Sep 2024 | - | $862.67M(-0.0%) |
| Jun 2024 | - | $862.95M(-4.2%) |
| Mar 2024 | - | $900.96M(+61.3%) |
| Dec 2023 | $54.90M(+68.0%) | $558.55M(+0.7%) |
| Sep 2023 | - | $554.65M(+109.7%) |
| Jun 2023 | - | $264.53M(-10.7%) |
| Mar 2023 | - | $296.12M(-11.5%) |
| Dec 2022 | $32.67M(-83.7%) | $334.43M(-9.2%) |
| Sep 2022 | - | $368.36M(-9.8%) |
| Jun 2022 | - | $408.51M(+27.8%) |
| Mar 2022 | - | $319.73M(-4.2%) |
| Dec 2021 | $200.69M | $333.71M(+72.6%) |
| Sep 2021 | - | $193.32M(-5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $203.76M(+35.2%) |
| Mar 2021 | - | $150.66M(-11.8%) |
| Dec 2020 | $93.09M(+130.8%) | $170.88M(-8.5%) |
| Sep 2020 | - | $186.82M(-8.9%) |
| Jun 2020 | - | $205.16M(+81.9%) |
| Mar 2020 | - | $112.80M(-4.7%) |
| Dec 2019 | $40.33M(-10.3%) | $118.39M(-10.1%) |
| Sep 2019 | - | $131.67M(-9.2%) |
| Jun 2019 | - | $144.97M(-7.8%) |
| Mar 2019 | - | $157.21M(-4.1%) |
| Dec 2018 | $44.97M(+216.9%) | $163.88M(-3.4%) |
| Sep 2018 | - | $169.65M(+148.0%) |
| Jun 2018 | - | $68.41M(-7.2%) |
| Mar 2018 | - | $73.74M(+419.6%) |
| Dec 2017 | $14.19M(+16.8%) | $14.19M |
| Dec 2016 | $12.15M | - |
FAQ
- What is Crinetics Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Crinetics Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of CRNX is $264.55M
What is the all time high annual cash & cash equivalents for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $264.55M
What is Crinetics Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, CRNX annual cash & cash equivalents has changed by +$209.65M (+381.89%)
What is Crinetics Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CRNX is $1.20B
What is the all time high quarterly cash & cash equivalents for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $1.35B
What is Crinetics Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, CRNX quarterly cash & cash equivalents has changed by +$333.91M (+38.69%)